Joseph K Belanoff

Chief Executive Officer, Director, Corcept Therapeutics

Bought, 12 months

$0.0M

Sold, 12 months

$10.4M

Companies

Latest trade

Jun 1, 2026

Companies

Corcept TherapeuticsChief Executive Officer, Director −$13.8M

Trades

CORT Sold 12,837 shares at $69.74 · planned $0.9M Jun 1

CORT Sold 40,000 shares at $50.10 · planned $2.0M May 1

CORT Sold 26,198 shares at $50.07 · planned $1.3M Mar 25

CORT Sold 40,000 shares at $79.77 · planned $3.2M Dec 1

CORT Sold 28,782 shares at $74.78 · planned $2.2M Nov 5

CORT Sold 11,218 shares at $74.08 · planned $0.8M Nov 3

CORT Sold 40,000 shares at $85.08 · planned $3.4M Oct 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.